Next Article in Journal
Toxin Profile of Gymnodinium catenatum (Dinophyceae) from the Portuguese Coast, as Determined by Liquid Chromatography Tandem Mass Spectrometry
Next Article in Special Issue
Studies toward the Total Synthesis of Itralamide B and Biological Evaluation of Its Structural Analogs
Previous Article in Journal
Marine Natural Products as Breast Cancer Resistance Protein Inhibitors
Previous Article in Special Issue
Two Novel Antioxidant Nonapeptides from Protein Hydrolysate of Skate (Raja porosa) Muscle
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2015, 13(4), 2030-2045;

Inhibition of N-Type Calcium Channels by Fluorophenoxyanilide Derivatives

School of Chemistry, Monash University, Clayton VIC 3800, Australia
CSIRO Manufacturing Flagship, Clayton South, VIC 3169, Australia
Institute for Molecular Bioscience, The University of Queensland, St Lucia QLD 4072, Australia
School of Chemical and Physical Sciences, Flinders University, Adelaide SA 5042, Australia
On exchange from Fakult
Authors to whom correspondence should be addressed.
Academic Editor: Alejandro M. Mayer
Received: 21 February 2015 / Revised: 18 March 2015 / Accepted: 26 March 2015 / Published: 13 April 2015
(This article belongs to the Special Issue Marine Peptides and Their Mimetics)
Full-Text   |   PDF [481 KB, uploaded 21 April 2015]   |  


A set of fluorophenoxyanilides, designed to be simplified analogues of previously reported ω-conotoxin GVIA mimetics, were prepared and tested for N-type calcium channel inhibition in a SH-SY5Y neuroblastoma FLIPR assay. N-type or Cav2.2 channel is a validated target for the treatment of refractory chronic pain. Despite being significantly less complex than the originally designed mimetics, up to a seven-fold improvement in activity was observed. View Full-Text
Keywords: N-type calcium channel; Cav2.2; channel blocker; pain; FLIPR N-type calcium channel; Cav2.2; channel blocker; pain; FLIPR

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Gleeson, E.C.; Graham, J.E.; Spiller, S.; Vetter, I.; Lewis, R.J.; Duggan, P.J.; Tuck, K.L. Inhibition of N-Type Calcium Channels by Fluorophenoxyanilide Derivatives. Mar. Drugs 2015, 13, 2030-2045.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top